Mandate

Vinge advises Semantix in connection with the acquisition of Tamarind

June 30, 2010

Vinge has advised Litorina’s portfolio company, Semantix in connection with the acquisition of Tamarind AB, one of Sweden’s leading translation companies providing specialist translation services.

As a result of the acquisition, Semantix has strengthened its position as the leading supplier of specialist language and communication services in the Nordic region. The group has a turnover of more than SEK 300 million and employs approximately 170 people and has more than 6 500 language consultants all over the world.

Semantix’s principal owner is Litorina, a private equity company which focuses on acquiring and developing small and medium sized companies in the Nordic region in co-operation with the management of these companies.

Vinge’s team consisted of responsible partner Johan Winnerblad and associates Joacim Rydergård and Philip Watson.

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026